The Quantellect read.As of Nov 19, 2026, 5 active firms cover Ibotta, Inc: 1 rate it Buy or better, 3 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets span $32.00 to $45.00, a moderate spread. The average target of $39.40 sits 29% below the current $55.61. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.34 next quarter toward $2.14 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Neutral
Strong Buy00%
Buy120%
Neutral360%
Sell120%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$39.40
-29.1% downside
Average target across 5 active firms as of Nov 19, 2026 vs $55.61 current
Highest Target$45.00
Average Target$39.40
Lowest Target$32.00
Detailed analyst forecasts for IBTA
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 1 of 5 active firms rate IBTA a Buy (3 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
IBTA EPS & revenue forecast
EPS · NEXT QUARTER
$0.34
Range $0.21 – $0.42 · 3 analysts · +44% YoY
Next period, 3 analysts expect Ibotta, Inc. to earn $0.34 a share (range $0.21 – $0.42), versus $0.24 a year earlier. Full-year consensus is $1.83, growing to $2.14 the year after.
REVENUE · NEXT QUARTER
$89.4M
Range $86.3M – $90.8M · 3 analysts · +8% YoY
Revenue is expected to reach $89.4M (range $86.3M – $90.8M), +8.4% year-over-year. Full-year consensus is $365.1M, rising to $392.1M next year.
Top analysts covering Ibotta, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IBTA.
#1
Bernie McTernan
Needham · Rank #482
Buy
$45.00-19.1% to target
Overall win rate
37%
+ Follow
#2
Eric Sheridan
Goldman Sachs · Rank #545
Sell
$32.00-42.5% to target
Overall win rate
31%
+ Follow
#3
Andrew Boone
JMP Securities · Rank #572
Neutral
No targeton IBTA
Overall win rate
22%
+ Follow
#4
Ken Gawrelski
Wells Fargo
Neutral
$40.00-28.1% to target
Coverage
—
+ Follow
#5
Mark Mahaney
Evercore ISI Group
Neutral
$42.00-24.5% to target
Coverage
—
+ Follow
IBTA stock forecast FAQ
What is IBTA's average 12-month price target?+
The 5 active firms with a live target average $39.40 for Ibotta, Inc. over the next 12 months, ranging from a $45.00 high to a $32.00 low, as of Nov 19, 2026.
Is IBTA stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 5 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 3 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for IBTA?+
The Street-high target is $45.00 (Needham), and the Street-low is $32.00 (Goldman Sachs). The average of all 5 active-firm targets is $39.40.
How many active Wall Street firms cover IBTA?+
5 active firms have a recognized rating on Ibotta, Inc. as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering IBTA?+
Among analysts who currently cover IBTA, Bernie McTernan of Needham has the strongest overall Quantellect track record (Rank #482). Their current call is Buy with a $45.00 target.
What is Ibotta, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.34 per share (range $0.21 – $0.42) across 3 analysts. Full-year EPS is projected at $1.83, rising to $2.14 the following year.
How much revenue is Ibotta, Inc. expected to report next quarter?+
Consensus revenue is $89.4M (range $86.3M – $90.8M). Full-year revenue is projected at $365.1M, growing to $392.1M next year.
Have analysts been upgrading or downgrading IBTA lately?+
As of Nov 19, 2026, 1 of 5 active firms rate IBTA a Buy (3 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IBTA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.